Defective mismatch-repair in patients with multiple primary tumours including colorectal cancer

被引:24
作者
Ericson, K [1 ]
Halvarsson, B
Nagel, J
Rambech, E
Planck, M
Piotrowska, Z
Olsson, H
Nilbert, M
机构
[1] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[2] Univ Lund Hosp, Dept Pathol, S-22185 Lund, Sweden
[3] Tech Univ Munich, Inst Expt Oncol & Therapeut Res, D-8000 Munich, Germany
关键词
multiple primary tumours; HNPCC; MSI; MMR; immunohistochemistry; MSH2; MLH1;
D O I
10.1016/S0959-8049(02)00584-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Individuals with an inherited predisposition to cancer development are at an increased risk of developing multiple tumours. Hereditary non-polyposis colorectal cancer (HNPCC) is one of the most common hereditary cancer syndromes and is estimated to account for approximately 2% of colorectal cancers. However, HNPCC individuals are at an increased risk of developing other tumour types such as cancers of the endometrium, urothelium. and small intestine. We have utilised a population-based regional cancer registry to identify all patients with double primary colorectal cancers and at least one additional malignancy and characterised the tumour spectrum in this patient group. We subsequently selected those 47 individuals who had developed at least four malignancies, including two colorectal cancers, for studies of the tumour characteristics associated with HNPCC. In total, these individuals developed 209 tumours, 156 of which were successfully retrieved. Microsatellite instability (MSI), a phenomenon caused by defective mismatch-repair (MMR), was identified in 63/154 (41%) evaluable tumours with a MSI-high pattern in 59 and a MSI-low pattern in four tumours. All tumours were immunohistochemically stained for the MMR proteins MLH1 and MSH2, with loss of expression in 55/63 (87%) MSI tumours and in 2/89 (2%) microsatellite stable (MSS) tumours. This loss affected MLHI in 24 tumours and MSH2 in 33 tumours. A concordant loss of expression for the same MMR protein in several tumours from the same individual, a pattern that strongly suggests an underlying germline MMR gene mutation, was found in 17/45 (38%) patients and affected MLH1 in 8 patients and MSH2 in 9 patients. We conclude that the development of multiple primary tumours, including synchronous or metachronous colorectal cancers, is associated with an increased frequency of MSI and loss of immunohistochemical expression of MLH1 and MSH2. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:240 / 248
页数:9
相关论文
共 37 条
[1]  
AALTONEN LA, 1994, CANCER RES, V54, P1645
[2]   Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome [J].
Aarnio, M ;
Mecklin, JP ;
Aaltonen, LA ;
NystromLahti, M ;
Jarvinen, HJ .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (06) :430-433
[3]  
Beck NE, 1997, BRIT J SURG, V84, P233, DOI 10.1002/bjs.1800840228
[4]  
Boland CR, 1998, CANCER RES, V58, P5248
[5]   Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer? [J].
Brown, SR ;
Finan, PJ ;
Bishop, DT .
GUT, 1998, 43 (05) :664-668
[6]   CUMULATIVE INCIDENCE OF METACHRONOUS COLORECTAL-CANCER [J].
CALI, RL ;
PITSCH, RM ;
THORSON, AG ;
WATSON, P ;
TAPIA, P ;
BLATCHFORD, GJ ;
CHRISTENSEN, MA .
DISEASES OF THE COLON & RECTUM, 1993, 36 (04) :388-393
[7]  
Cederquist K, 2001, INT J CANCER, V91, P486, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1093>3.0.CO
[8]  
2-P
[9]  
Dietmaier W, 1997, CANCER RES, V57, P4749
[10]  
ENBLAD P, 1990, CANCER, V65, P2091, DOI 10.1002/1097-0142(19900501)65:9<2091::AID-CNCR2820650934>3.0.CO